NCT06577857View on ClinicalTrials.gov

Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study

RecruitingOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

November 4, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Open Angle Glaucoma
Interventions
DEVICE

Inferonasal Minimally Invasive Micro Sclerostomy

The Inferonasal MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the inferonasal quadrant of the eye.

Trial Locations (1)

Unknown

RECRUITING

S. Malayan Eye Center, Yerevan

All Listed Sponsors
lead

Sanoculis Ltd

INDUSTRY